Vascular pathology of multiple sclerosis

Neurological Research

Volumn 34, Issue 8, 2012, Pages 735-737

  Zivadinov, Robert ^a,b   Alexander, Steven J ^c   Minagar, Alireza ^d  

^a UNIVERSITY AT BUFFALO   (United States)

^b JACOBS NEUROLOGICAL INSTITUTE   (United States)

^c Microbiology and Immunology   (United States)

^d Louisiana State University Health Sciences Center at Shreveport   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; CHRONIC CEREBROSPINAL VENOUS INSUFFICIENCY; DISEASE ASSOCIATION; EDITORIAL; HUMAN; MEDICAL RESEARCH; MULTIPLE SCLEROSIS; SUSCEPTIBILITY WEIGHTED IMAGING; VASCULAR DISEASE;

HUMANS; MULTIPLE SCLEROSIS; VASCULAR DISEASES;

EID: 84866233994     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/0161641212Z.000000000114     Document Type: Editorial

References (31)

1. Frohman EM, Racke MK, Raine CS. Multiple sclerosis - the plaque and its pathogenesis. N Engl J Med. 2006;354:942-955.
2. Ramagopalan SV, Dobson R, Meier UC, Giovannoni G. Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol. 2010;9:727-739.
3. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol. 2007;61:288-299.
4. Hawkes CH. Smoking is a risk factor for multiple sclerosis: a metanalysis. Mult Scler. 2007;13:610-615.
5. Minagar A, Zivadinov R. Pathophysiology of demyelinating disorders. Pathophysiology. 2011;18:1-2.
6. Minagar A, Maghzi A, McGee J, Alexander S. Emerging roles of endothelial cells in multiple sclerosis pathophysiology and therapy. Neurol Res. 2012;34:738-745.
7. Adams C. Perivascular iron deposition and other vascular damage in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1988;51:260-265.
8. Charcot J. Histologie de la sclerose en plaques. Gaz Hopit Civils Milit. 1868;41:554-566.
9. Fog T. The topography of plaques in multiple sclerosis with special reference to cerebral plaques. Acta Neurol Scand Suppl. 1965;15:1-161.
10. Putnam T. The pathogenesis of multiple sclerosis, a possible vascular factor. N Engl J Med. 1933;209:786-790.
11. Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T. Cortical lesions in multiple sclerosis. Brain. 1999;122:17-26.
12. Hammond KE, Metcalf M, Carvajal L, Okuda DT, Srinivasan R, Vigneron D, et al. Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol. 2008;64:707-713.
13. Tallantyre EC, Brookes MJ, Dixon JE, Morgan PS, Evangelou N, Morris PG. Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRI. Neurology. 2008;70:2076-2078.
14. Zivadinov R, Poloni GU, Marr K, Schirda CV, Magnano CR, Carl E, et al. Decreased brain venous vasculature visibility on susceptibility-weighted imaging venography in patients with multiple sclerosis is related to chronic cerebrospinal venous insufficiency. BMC Neurol. 2011;11:128.
15. Beggs C, Shepherd S, Dwyer M, Polak P, Magnano C, Carl E, et al. Sensitivity and specificity of SWI venography for detection of cerebral venous alterations in multiple sclerosis. Neurol Res. 2012;34:793-801.
16. Zamboni P, Galeotti R, Menegatti E, Malagoni AM, Tacconi G, Dall'Ara S, et al. Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2009;80:392-399.
17. Zamboni P, Galeotti R, Menegatti E, Malagoni AM, Gianesini S, Bartolomei I, et al. A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. J Vasc Surg. 2009;50:1348-58.e1-e3.
18. Zamboni P, Menegatti E, Galeotti R, Malagoni AM, Tacconi G, Dall'Ara S, et al. The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis. J Neurol Sci. 2009;282:21-27.
19. Singh AV, Zamboni P. Anomalous venous blood flow and iron deposition in multiple sclerosis. J Cereb Blood Flow Metab. 2009;29:1867-1878.
20. Zamboni P. The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis. J R Soc Med. 2006;99:589-593.
21. Zivadinov R, Ramanathan M, Dolic K, Marr K, Karmon Y, Siddiqui AH, et al. Chronic cerebrospinal venous insufficiency in multiple sclerosis: diagnostic, pathogenetic, clinical and treatment perspectives. Expert Rev Neurother. 2011;11:1277-1294.
22. Morovic S, Zamboni P. CCSVI is associated with multiple sclerosis. Neurol Res. 2012;34:770-779.
23. Utriainen D, Trifan G, Sethi S, Elias S, Hewett J, Feng W, et al. Magnetic resonance imaging signatures of vascular pathology in multiple sclerosis. Neurol Res. 2012;34:780-792.
24. Feng W, Utriainen D, Trifan G, Elias S, Sethi S, Hewett J, et al. Characteristics of flow through the internal jugular veins at cervical C2/C3 and C5/C6 levels for multiple sclerosis patients using MR phase contrast imaging. Neurol Res. 2012;34:802-809.
25. Khan O, Filippi M, Freedman MS, Barkhof F, Dore-Duffy P, Lassmann H, et al. Chronic cerebrospinal venous insufficiency and multiple sclerosis. Ann Neurol. 2010;67:286-290.
26. Diaconu C, Staugaitis S, Fox R, Rae-Grant A, Schwanger C, McBride J. A technical approach to dissecting and assessing cadaveric veins pertinent to chronic cerebrospinal venous insufficiency in multiple sclerosis. Neurol Res. 2012;34:810-818.
27. D'Haeseleer M, Cambron M, Vanopdenbosch L, De Keyser J. Vascular aspects of multiple sclerosis. Lancet Neurol. 2011;10:657-666.
28. Christiansen C. Risk of vascular disease in patients with multiple sclerosis: a review. Neurol Res. 2012;34:746-753.
29. Karmon Y, Ramanathan M, Minagar A, Zivadinov R, Weinstock-Guttman B. Arterial, venous and other vascular risk factors in multiple sclerosis. Neurol Res. 2012;34:754-760.
30. Zivadinov R, Ramanathan M, Ambrus J, Hussein S, Ramasamy D, Dwyer M, et al. Anti-phospholipid antibodies are associated with response to interferon-beta-1a treatment in MS: results from a 3-year longitudinal study. Neurol Res. 2012;34:761-769.
31. Dolic K, Weinstock-Guttman B, Marr K, Valnarov V, Carl E, Hagemeier J, et al. Heart disease, overweight and cigarette smoking are associated with increased prevalence of extra-cranial venous abnormalities. Neurol Res. 2012;34:819-827.